Last reviewed · How we verify
Uptravi® Film Coated Tablets — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Uptravi® Film Coated Tablets (Uptravi® Film Coated Tablets) — Humanis Saglık Anonim Sirketi.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Uptravi® Film Coated Tablets TARGET | Uptravi® Film Coated Tablets | Humanis Saglık Anonim Sirketi | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Uptravi® Film Coated Tablets CI watch — RSS
- Uptravi® Film Coated Tablets CI watch — Atom
- Uptravi® Film Coated Tablets CI watch — JSON
- Uptravi® Film Coated Tablets alone — RSS
Cite this brief
Drug Landscape (2026). Uptravi® Film Coated Tablets — Competitive Intelligence Brief. https://druglandscape.com/ci/uptravi-film-coated-tablets. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab